Regarding the risks, there is no patent risk, as the core patent is expected to expire only after 2031
60 units at 60 mg/mL: 36 mg of tirzepatide The 60 mg/mL concentration is rare and extremely potent
It is generally well-tolerated, with the following side effects [9][18]: GI symptoms (most common): Nausea, vomiting, diarrhea, and abdominal discomfort, particularly at doses above 1,200 mg/day Sulfurous taste/smell: NAC has a distinct sulfur odor and taste that some find unpleasant Headache: Occasionally reported Anaphylactoid reactions (IV use only): Infusion-related reactions including flushing, itching, bronchospasm, and hypotension occur in approximately 10-20% of patients receiving IV NAC for acetaminophen overdose [18] Upper limit: There is no established UL for NAC
Mindfulness, deep breathing, yoga, or a short walk can be enough to distract you
"Prescribing a compounded product may expose pharmacists to liability if a patient has a negative outcome, particularly if a TGA approved product is available to treat the patient's medical condition," it said
Other factors may have played a role
.png)
